A New Generation of Drug Therapies Requires New Business Strategies Alex Vadas Jeff Holder Adam Siebert Read more
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
Smart Chart Mental and Behavioral Health Look Forward to Transforming the Patient Journey in Mental Health December 14, 2023
Executive Insights Life Sciences & Pharma Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives September 1, 2023
Executive Insights Organization & Performance Disruptive Trends in Corporate Transformation: Converting Ideas Into Action August 23, 2023